Pediatric neurology · 2013
Levetiracetam-induced anaphylaxis in a neonate.
Клинический случайСтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Koklu Esad, Ariguloglu Erdal Avni, Koklu Selmin
Аннотация
BACKGROUND: Neonatal seizures are often refractory to treatment with initial antiseizure medications. Clinicians turn to agents such as levetiracetam despite the paucity of published data regarding its safety, tolerability, or efficacy in the neonatal population.
PATIENT PRESENTATION: We describe a neonate who developed anaphylactic shock developing after receiving intravenous levetiracetam.
RESULTS: This is the first neonate to develop anaphylactic shock due to intravenous administration of levetiracetam.
CONCLUSION: Clinicians should be aware of this potentially fatal adverse effect occurring with intravenous levetiracetam in newborns.
PATIENT PRESENTATION: We describe a neonate who developed anaphylactic shock developing after receiving intravenous levetiracetam.
RESULTS: This is the first neonate to develop anaphylactic shock due to intravenous administration of levetiracetam.
CONCLUSION: Clinicians should be aware of this potentially fatal adverse effect occurring with intravenous levetiracetam in newborns.